Clinical Trials Directory

Trials / Completed

CompletedNCT00895349

Impact of Positron Emission Tomography (PET) Imaging in Women With Locally Advanced Cervical Cancer (PET LACE Trial)

The Impact of Positron Emission Tomography (PET) Imaging in Women With Locally Advanced Cervical Cancer

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
171 (actual)
Sponsor
Ontario Clinical Oncology Group (OCOG) · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this trial is to improve the clinical management and outcome of patients with locally advanced cervical cancer by using positron emission tomography-computed tomography (PET-CT) imaging. There is considerable debate worldwide regarding the utility of PET for staging cervical cancer. Although there are studies on the accuracy (sensitivity and specificity) of PET in cervical cancer, there are currently no prospective randomized studies on how PET information affects treatment decisions and outcomes.

Detailed description

Cervical cancer is the second most common cause of cancer deaths worldwide. In Canada, it is estimated that in 2009 there will be 1,300 new cases of cervical cancer and that 380 women will die of this disease. The corresponding 2009 data for Ontario is 500 new cases and 140 deaths. In Canada, cervical cancer screening with the Pap test allows for the diagnosis and curative treatment of precancerous lesions of the cervix or early cervical cancers. Symptoms of cervical cancer include vaginal bleeding and discharge. Unfortunately these are often associated with more advanced disease. The costs associated with health care are increasing. PET is an expensive imaging modality. Given that resources for health care are not unlimited, there needs to be high quality evidence of an intervention such as PET's efficacy.

Conditions

Interventions

TypeNameDescription
PROCEDURECT Abdomen and Pelvis scan + whole body PET-CT scanPre-treatment scan
PROCEDURECT Abdomen and Pelvis scanPre-treatment scan

Timeline

Start date
2010-04-01
Primary completion
2014-06-01
Completion
2019-08-01
First posted
2009-05-08
Last updated
2020-01-29

Locations

6 sites across 1 country: Canada

Source: ClinicalTrials.gov record NCT00895349. Inclusion in this directory is not an endorsement.